aTyr Pharma (LIFE) Short Interest Ratio & Short Volume

Short interest is the volume of aTyr Pharma shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 436,900 shares of LIFE short. Learn More on aTyr Pharma's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LIFE shares currently have a short interest ratio of 1.0. Learn More on aTyr Pharma's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of aTyr Pharma: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

aTyr Pharma saw a increase in short interest in March. As of March 31st, there was short interest totaling 436,900 shares, an increase of 51.0% from the previous total of 289,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to aTyr Pharma: Vigil Neuroscience, Inc. (7.06%), Outlook Therapeutics, Inc. (6.16%), Zura Bio Limited (3.32%), Cardiol Therapeutics Inc. (0.53%), bluebird bio, Inc. (27.21%), DBV Technologies S.A. (0.28%), Molecular Partners AG (0.13%), Sangamo Therapeutics, Inc. (6.38%), Candel Therapeutics, Inc. (1.03%), Athira Pharma, Inc. (2.86%),

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

Short selling LIFE is an investing strategy that aims to generate trading profit from aTyr Pharma as its price is falling. LIFE shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for aTyr Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LIFE, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LIFE, twice per month. The most recent reporting period available is March, 31 2024.